Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-049910
Filing Date
2021-04-13
Accepted
2021-04-13 21:59:19
Documents
1
Period of Report
2021-04-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2112857-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2112857-2_4seq1.xml 4 3934
  Complete submission text file 0001104659-21-049910.txt   5386
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 RADNOR CORPORATE CENTER STE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address
Pfanstiel Steven (Reporting) CIK: 0001856059 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 21824431